This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Results
Metoclopramide users were over three times more likely to begin use of L-dopa therapy compared with non-users (OR=3.09; 95% CI 2.25 to 4.26).
Notes:
Our results—We found that metoclopramide users were over three times more likely to begin levodopa therapy as compared with non-users of metoclopramide.
Previous Slide Contents Next Slide 
5600 Fishers Lane Rockville, MD 20857